(a) A health benefit plan that provides coverage for diagnostic medical procedures must provide to each woman 18 years of age or older enrolled in the plan coverage for expenses for an annual medically recognized diagnostic examination for the early detection of ovarian cancer and cervical cancer.
(b) Coverage required under this section includes at a minimum:
(1) a CA 125 blood test;
(2) a conventional Pap smear screening or a screening using liquid-based cytology methods, as approved by the United States Food and Drug Administration, alone or in combination with a test approved by the United States Food and Drug Administration for the detection of the human papillomavirus; and
(3) any other test or screening approved by the United States Food and Drug Administration for the detection of ovarian cancer.

(c) A screening test required under this section must be performed in accordance with the guidelines adopted by:
(1) the American College of Obstetricians and Gynecologists; or
(2) another similar national organization of medical professionals recognized by the commissioner.